Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder
Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder
复制标题
DOI:
10.1016/s0006-3223(99)00286-3
复制
发表时间:
2000-02-01
影响因子:
10.6
通讯作者:
Rosenberg, DR
中科院分区:
文献类型:
--
作者:
Fitzgerald, KD;Moore, GJ;Rosenberg, DR
Background: Neurobiological abnormalities in rite thalamus, particularly the dorsomedial nucleus of the thalamus, are believed to be involved in the pathophysiology of obsessive-compulsive disorder. Although obsessive-compulsive disorder commonly arises in childhood and adolescence, no prior study has examined the thalamus in pediatric obsessive-compulsive disorder patients.Methods: In this study, N-acetyl-aspartate, a putative marker of neuronal viability, creatine/phosphocreatine, and choline levels were measured in the lateral and medial subregions of the left and right thalami using a multislice proton magnetic resource spectroscopic imaging sequence in 11 treatment-naive, nondepressed obsessive-compulsive disorder outpatients, 8-15 years old, and 11 case-matched control subjects.Results: A significant reduction in N-acetyl-aspartate/choline and N-acetyl-aspartate/(creatine/phosphocreatine + choline) was observed in both the right and left medial thalami in obsessive compulsive disorder patients compared with control subjects. The N-acetyl-aspartate/choline and N-acetyl-aspartate/(creatine/phosphocreatine + choline) levels did nor differ significantly between case-control pairs in either rite left or the right lateral thalamus. Reduction in N-acetyl-aspartate levels in the left menial thalamus was inversely correlated with increased obsessive-compulsive disorder symptom severity.Conclusions: These findings provide new evidence of localized functional neurochemical marker abnormalities ill the thalamus in pediatric obsessive-compulsive disorder, Our results must be considered preliminary, however, given the small sample size. Biol Psychiatry 2000, 47, 174-182 (C) 2000 Society of Biological Psychiatry.